6-41684916-G-T
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001271944.2(TFEB):c.1114C>A(p.Leu372Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000216 in 1,576,558 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001271944.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TFEB | NM_001271944.2 | c.1114C>A | p.Leu372Met | missense_variant | 9/9 | ENST00000373033.6 | NP_001258873.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TFEB | ENST00000373033.6 | c.1114C>A | p.Leu372Met | missense_variant | 9/9 | 1 | NM_001271944.2 | ENSP00000362124 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000788 AC: 12AN: 152230Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000733 AC: 15AN: 204708Hom.: 0 AF XY: 0.0000631 AC XY: 7AN XY: 110906
GnomAD4 exome AF: 0.0000154 AC: 22AN: 1424328Hom.: 0 Cov.: 34 AF XY: 0.0000142 AC XY: 10AN XY: 704648
GnomAD4 genome AF: 0.0000788 AC: 12AN: 152230Hom.: 0 Cov.: 33 AF XY: 0.000121 AC XY: 9AN XY: 74380
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 20, 2023 | The c.1114C>A (p.L372M) alteration is located in exon 10 (coding exon 8) of the TFEB gene. This alteration results from a C to A substitution at nucleotide position 1114, causing the leucine (L) at amino acid position 372 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at